IFA
12.9.2019 11:59:07 CEST | Business Wire | Press release
IFA Berlin has turned out to be another huge success story with nearly 2,000 exhibitors, 245,000 visitors, and a new all-time high for international attendance, with more than 50 percent of trade visitors coming from abroad. Three big technology trends dominated IFA across both consumer electronics and home appliances: voice, artificial intelligence and connectivity, especially given the rapid roll-out of high-speed, high bandwidth 5G mobile networks.
Two IFA Keynotes – by Huawei CEO Richard Yu and Qualcomm President Cristiano Amon - focused on how 5G-connectivity can push the power of artificial intelligence to the very edge of computing – in the devices, into vehicles and into industrial applications.
Anthony Wood , the CEO of Roku – which powers one third of all set-top boxes in the United States – used his keynote to outline his vision of how online streaming will dominate the TV experience, and announced his company’s expansion to the UK, with plans to move to other European countries as well. Hakan Bulgurlu , the CEO of Arçelik, dedicated his keynote to demanding industry action against climate change and plastic waste.
IFA’s innovation hub – IFA NEXT – also set new records with more start-ups and innovation leaders than ever spread across two halls, alongside research institutes from countries like Germany, Japan and Korea. This year, IFA NEXT hosted Japan as its first Global Innovation Partner country; the Japan pavilion was showcasing the newest ideas and innovations for how machines and humans can interact.
Keita Nishiyama , Director General of Commerce and Information Policy - Bureau, Ministry of Economy, Trade and Industry says "We hope that Japan’s Interface with Consideration and Sensibility has inspired IFA visitors to embrace the future and continue on the path of innovation. As the first partner country of IFA NEXT - we look forward to staying in touch with you. Please follow us as Ninja does!”
Once again, IFA Berlin lived up to its reputation as the world’s most important trade show for consumer electronics and home appliance.
"As an important driving force for trade and industry and the world's most important platform for consumer electronics and home appliances, IFA 2019 met the high expectations. With its large number of innovations, it has a positive influence on the mood in the international markets. With an unexpectedly stable high order volume in regard to the current market situation, the foundation was laid for a successful year-end business," explains Hans-Joachim Kamp , Chairman of the Supervisory Board of IFA organizer gfu Consumer & Home Electronics.
"We are satisfied with the results of IFA 2019. Accordingly, the household appliance industry is optimistic about the future. This year too, IFA has strengthened its position as the world's significant trade show for home appliances and made a positive contribution to the market development," states Dr. Reinhard Zinkann , Chairman of the ZVEI.
The CEO of Messe Berlin, Dr. Christian Göke says IFA had once again shown the "power of co-innovation, where inventors in different sectors and industries inspire each other." He warned that trade wars, trade barriers and political barriers would harm consumers not just by making products more expensive, but by slowing down innovation itself. Picking up a theme developed in one of IFA’s most famous keynotes, by Albert Einstein in 1930, Dr. Göke said that in today’s day and age Einstein would probably "call on the best and the brightest minds in the world, whoever they are, and wherever they live, whichever country they call their home, to pool their knowledge and co-innovate to create a better world."
IFA Executive Director Jens Heithecker was hugely impressed by the level of innovation: "As the number of exhibitors has grown, so did the quality and quantity of innovations as well as the number of product premieres that were shown here in Berlin for the first time."
Global media attendance has gone up yet again; the journalists coming to Berlin work for media organisations covering 160 countries around the world. This shows how important IFA is in the calendar for technology and lifestyle journalists. This year, IFA attracted some 2.800 international journalists from around the world.
Among the broadcasters reporting from IFA Berlin were Al Jazeera from the Arab Emirates, NDTV from India, Nine Network from Australia, the BBC from the United Kingdom, IBA International from Israel, TEKNAVI from Finland, CNBC from the USA, CGTN / CCTV, Global Times as well as the Phoenix Group from China. From France teams from Eurosport, 01net TV, LCI, BFM TV, OUATCH.tv, France 24 and ES 1 reported on the latest IFA news. News agencies such as AP and Reuters were represented, alongside public broadcasters working through the EBU and private broadcasters cooperating through ENEX.
SHIFT – Future of Mobility
SHIFT, the two-day convention on how new technologies are shaping the Future of Mobility, has grown strongly compared to the previous year; among the speakers were top executives from industry giants such as AXA insurance, BMW, Daimler/Smart, Ford Fujitsu and Volkswagen, start-ups like 2Getthere, Iomob, LISNR, Trafi, Vive La Car, what3words and Wundermobility, and mobility pioneers like Zipcar Founder Robin Chase, the former CTO of Barcelona Francesca Bria, former Tata Motors CEO Venkat Sumantran, and a very unusual automotive consultant, Jay Ward the creative director of the Cars Franchise at Pixar Animation Studios.
IFA Global Markets
IFA Global Markets exclusively accessible to trade visitors, suppliers, manufacturers and OEMs / ODMs established itself as a significant part of IFA.
Dirk Koslowski
, IFA Director, states: "IFA Global Markets has been growing continuously for four years now. It is thus the leading platform in Europe for the supplier industry and has firmly established its position as the largest sourcing show in Europe."
Covering 20,000 square meters, the B2B marketplace IFA Global Markets was once again fully booked.
IFA Global Events – Save the Dates
CE China 2019
19 - 21 September, Guangzhou, China
CE Week 2020
10 - 11 June, New York, USA
IFA Global Press Conference 2020
2 - 5 April, Cyprus
IFA 2020
4 - 9 September
2 - 3 September, IFA Media Days
2 September, IFA Opening Press Conference, 1 p.m.
6 - 9 September IFA Global Markets
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005397/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
